Press Release Remedy Plan Therapeutics Announces Multiple Presentations at the AACR Annual Meeting 2026 18 hours ago
Press Release Remedy Plan Therapeutics Announces Multiple Development and Corporate Milestones as First-In-Class Hyperbolic NAMPT Inhibitor, RPT1G, Advances in Phase 1 Dose Escalation Trial in AML/MDS Sep 15